Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality

NCT02378337 is registered in ClinicalTrials.gov with Hospital Sao Rafael as lead sponsor.

NCT NCT02378337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02378337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality
Lead sponsor
Hospital Sao Rafael
Phase
Observational
Overall status
Completed
Start date
September 30, 2014
Completion date
March 31, 2016
Enrollment
335 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin disease, malignant melanoma of the skin, malignant neoplasm of breast, malignant neoplasm of bronchus and lung, malignant neoplasm of colon, malignant neoplasm of small intestine, non-hodgkin lymphoma, follicular (nodular), secondary neoplasm malignant and unspecified lymph nodes